AT-7519 is an ATP competitive CDK inhibitor showing activity against CDK1, 2, 4, 6, and 9. It causes cell cycle arrest followed by apoptosis in human tumor cells and inhibits tumor growth in human tumor xenograft models. It also induces apoptosis in multiple myeloma cells via GSK-3? activation.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































